Overzicht Proefschriften

Tips in using the search/filter fields

Tips in using the search/filter fields
Select on a part of the content: ede Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes) Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010 Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011 Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.
Go to page:
  • of 6

Displaying 51-100 of 270 results.
TitelPromovendusPromotor 1Promotor 2Copromotor 1Copromotor 2UniversiteitPromotiejaarTrefwoorden
Optimizing protease inhibitor-based antiretroviral therapy for HIV-1 infected Thai adults and childrenLugt J. van der, dr.Lange J.M.A., prof. dr.Ananworanich J., dr.Burger D.M., prof. dr.Universiteit van Amsterdam (UvA)2010Antiretroviral; HIV; Pharmacokinetics; Clinical pharmacology; therapeutic drug monitoring
Human pharmacology of current and novel gaba(a)-ergic treatments for anxietyChen X., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Jacobs G.E., dr.Universiteit Leiden (UL)2017Anxiety Human pharmacology GABA-ergic treatment
Development and use of biomarkers in clinical development of new therapies for chronic airway diseaseZuiker R.G.J.ABurggraaf J., prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2016Asthma COPD Biomarkers Allergen challenges Inflammation
Towards better treatment outcomes in childhood asthmaKoster E.S., PhDRaaijmakers J.A.M., prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2011Asthma; Children; Treatment Outcomes; Epidemiology;
Individualized dosing of serotherapy in allogeneic hematopoietic cell transplantationAdmiraal R., PhDKnibbe C.A.J., prof. dr.Boelens J.J., dr.Bredius R.G.M., dr.Universiteit Leiden (UL)2017ATG; Population PK; Stem cell transplantation; Immune reconstitution; Serotherapy;
Future drugs in atherosclerotic cardiovascular diseasePoelgeest E.P vanBurggraaf J., prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2018Atherosclerosis Systemic inflammation Hypercholesterolemia PCSK9 inhibitor TLR4 sinaling Acute kidney injury Endothelial dysfunction Human endotoxemia model Ex vivo LPS challenge test Invivo LPS challenge test
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillationWiersma M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2016Atrial fibrillation;
Targeting proteostasis in atrial fibrillationZhang D., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2015Atrial fibrillation; Modelling-&-simulations;
Loss of proteostasis as a substrate for Atrial Fibrilation.Meijering R.A.M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2014Atrial fibrillation; Proteostasis;
From data to models : reducing uncertainty in benefit risk assessment : application to chronic iron overload in childrenBellanti F., PhDDanhof M., prof. dr.Della Pasqua O.E., dr.Universiteit Leiden (UL)2015Benefit-risk assessment; Paediatrics; Iron chelations; PK-PD modelling; Modelling-&-simulations; Multi-criteria-decision-analysis; Iron-overload; Deferiprone; Deferoxamine;
Benefits and risks for the individual : anticoagulation for patients with atrial fibrillationHam H.A. van den, PhDLeufkens H.G.M., prof. dr.Klungel O.H., prof. dr.Staa T.J. van, prof. dr.Universiteit Utrecht (UU)2016Benefit-risk balance; Atrial fibrillation; Oral anticoagulants; Observational studies; Individuals;
Pharmacovigilance of biologicals : dynamics in post-approval safety learningVermeer N.S., PhDLeufkens H.G.M., prof. dr.Egberts A.C.G., prof. dr.Bruin M.L. de, prof. dr.Straus S.M.J.M., dr.Universiteit Utrecht (UU)2015Biologicals; Biosimilars; Pharmacovigilance; Adverse drug reactions; Regulatory science; Traceability; Risk management plan;
Monitoring patients using clozapineMan W.H., PhDEgberts A.C.G., prof. dr.Solinge W.W. van, prof. dr.Wilting I., dr.Heerdink E.R., dr.Universiteit Utrecht (UU)2018Biomarkers; Adherence; Monitoring; Sialorrhea; Inflammation; Glycopyrrolate; Schizophrenia; Antipsychotics; Pharmacovigilance;
Novel biomarker panels in diabetic kidney disease: predicting disease progression and response to therapy, and monitoring drug effectPena M.J., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2015Biomarkers; Diabetes mellitus; Kidney;
Sticky & Dirty Proteins- or on the poorly characterised, peculiar, pharmacokinetic and immunostimulatory aspects of biopharmaceuticalsReijers J.A.A.Burggraaf J., prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2018Biopharmaeuticals Biologics Clinical Pharmacology Pharmacokinetics Adverse immunostimulation Immunotoxicity Drug impurity Drug contamination Monoclonal antibody
Unravelling the link between diabetes, insulin treatment and breast cancerBronsveld H.K., PhDBoer A. de, prof. dr.Bruin M.L. de, prof. dr.Schmidt M.K., dr. ir.Universiteit Utrecht (UU)2017Breast cancer; Risk factors; Diabetes mellitus; Insulin growth factor; Diabetes treatment;
New insights into the role of breast cancer resistance protein in endocrine and metabolic processesDankers A.C.A., PhDRussel F.G.M., prof. dr.Sweep C.G.J., prof. dr.Masereeuw R., prof. dr.Radboud Universiteit (RU)2014Cancer; Breast cancer;
Bioanalysis and clinical pharmacology of tamoxifen in breast cancerJager N.G.L., PhDBeijnen J.H., prof. dr.Schellens J.H.M., prof. dr.Rosing H., dr.Universiteit Utrecht (UU)2014Cancer; Clinical pharmacology;
Clinical pharmacology of genotype-directed anticancer therapy - Towards rational combination strategiesGeel R.M.J.M. van, PhDSchellens J.H.M., prof. dr.Beijnen J.H., prof. dr.Huitema A.D.R., prof. dr.Cats A., dr.Universiteit Utrecht (UU)2016Cancer; Genetics; BRAF; Colorectal cancer; Combination therapy; p53-deficient ovarian cancer; AZD1775; Treatment individualization;
The role of pharmacogenetics in osteosarcomaHagleitner M.M., PhDHoogerbrugge P.M., prof. dr.Guchelaar H.J., prof. dr.Loo D.M.W.M. te, dr.Coenen M.J.H., dr.Radboud Universiteit (RU)2015Cancer; Osteosarcoma; Pharmacogenetics; Genetics; Chemotherapy;
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approachKappers M.H.W., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Cancer; Pharmacology; Antihypertensive drugs;
Novel approaches in clinical development of cannabinoid drugs Klumpers L.E., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Cannabinoids; THC; CB1 antagonists; Pharmacokinetics; Clinical pharmacology; Pharmacodynamics; Feeling high; PK-PD modelling; Resting state FMRI; Rimonabant;
The aging cardiovascular system: genetic and epigenetic determinants of vascular outcomes and cardiometabolic riskPortilla Fernández EDanser A.H.J., prof. dr.Ikram MA, prof.dr.Roks A.J.M., dr.Dehghan A, dr.Erasmus Universiteit Rotterdam (EUR)2019Cardiac aging; Cardiovascular disease; Genetics; Epidemiology; Epigenetics; Vascular reactivity; Pharmacology;
Techniques to improve neurological outcome after cardiac surgeryKok W.F., PhDHenning R.H., prof. dr.Absalom A.R., prof. dr.Scheeren T.W.L., prof. dr.Rijksuniversiteit Groningen (RUG)2017Cardiac surgery; Clinical pharmacology; Neurological outcome;
Vascular reactivity in cardiopulmonary bypassSamarska I., PhDHenning R.H., prof. dr.Struys M.M.R.F., prof. dr.Buikema J.H., dr.Epema A.H., dr.Rijksuniversiteit Groningen (RUG)2011Cardiopulmonary bypass; Vascular reactivity;
Biomarkers as assessment of drug efficacy in cardiovascular diseaseSmink P.A., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Bakker S.J.L., prof. dr.Rijksuniversiteit Groningen (RUG)2013cardiovascular disease biomarkers drug efficacy
The role of aldosterone and aldosterone blockade in hypertensionJansen P.M., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2013Cardiovascular disease; Antihypertensive drugs; Pharmacology;
Multimodality ImAging of Cardiovascular Dysfunction: Risk factors, diagnostics and treatment optionsThiel B.S. van, PhDKanaar R., prof. dr.Danser A.H.J., prof. dr.Essers J., dr.Pluijm I. van der, dr.Erasmus Universiteit Rotterdam (EUR)2017Cardiovascular disease; Imaging; Aging; Risk factors; Diagnostics; Treatment options
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factorsBatenburg W.W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Cardiac aldosterone: origin and effectsChai W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraineMehrotra S., dr.Saxena P.R., prof. dr.Danser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2006Cardiovascular disease; Pharmacology;
Vascular aging from DNA damage to protectionĎurik M., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2012Cardiovascular disease; Pharmacology;
Vascular pharmacology of migraine and preeclampsia: Problems of the fair sexGupta S., dr.Saxena P.R., prof. dr.Danser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2006Cardiovascular disease; Pharmacology;
(Pro)renin revisited: new insights from studies in mast cellsKrop M., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2009Cardiovascular disease; Pharmacology; Prorenin;
The (pro)renin receptor: moving away from prorenin?Lu X., PhDDanser A.H.J., prof. dr.Meima M.E., dr.Erasmus Universiteit Rotterdam (EUR)2014Cardiovascular disease; Pharmacology; Prorenin;
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibitionEsch J.H.M. van, dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2008Cardiovascular disease; Pharmacology; Renin-angiotensin system;
Multimodality ImAging of Cardiovascular Dysfunction: Risk Factors, Diagnostics and Treatment OptionsThiel B.S. van, PhDKanaar R., prof. dr.Danser A.H.J., prof. dr.Essers J., dr.Pluijm I. van der, dr.Erasmus Universiteit Rotterdam (EUR)2017Cardiovascular disease; Risk factors; Treatment options;
Carotid artery contrast enhanced ultrasoundKate G.L. ten, PhDSijbrands E.J.G., prof. dr.Danser A.H.J., prof. dr.Schinkel A.F.L., Dr.Erasmus Universiteit Rotterdam (EUR)2014Cardiovascular disease; Vascular reactivity;
Endothelial dysfunction in cardiovascular diseaseHeuvel M. van den, PhDDuncker D.J.G.M., Prof.dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2018Cardiovascular disease; Vascular reactivity; Cholesterol;
DNA Damage-related Vascular Dysfunction: Pathways and InterventionsBautista-Niño P.K., PhDDanser A.H.J., prof. dr.Franco Duran O.H., Prof.dr.Roks A.J.M., dr.Ghanbari M., dr.Erasmus Universiteit Rotterdam (EUR)2017Cardiovascular disease; Vascular reactivity; DNA damage;
Experimental focal cerebral ischemia: optimalisation of models and therapeutic interventionsShanbhag N.C., PhDHenning R.H., prof. dr.Schilling L., prof. dr.Rijksuniversiteit Groningen (RUG)2016Cerebral ischemia;
COMPARE: Care in Oncolytic Medication surveillance:Pharmacovigilance, Acceptability, Risks and EventsOijen B.P.C. van, dr.Schouten H.C., prof. dr.Kuy P.H.M. van der, dr.Janknegt R., PharmD PhDUniversiteit Maastricht (UM)2015Chemotherapy; Clinical pharmacology; Pharmaceutical care;
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergyAhmadizar F., PhDBoer A. de, prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2016Children; Diabetes mellitus; Allergy
Comorbidities, complications and treatment of childhood obesityLentferink Y.E., PhDKnibbe C.A.J., prof. dr.Vorst M.M.J. van der, dr.Universiteit Leiden (UL)2019Children; Obesity; Asthma; ADHD; Insulin resistance; Metformin; Cardiovascular diseases; Obese children; Arterial stiffness; Skin autofluorescence;
Optimization of electronic prescribing in pediatric patientsMaat B., PhDEgberts A.C.G., prof. dr.Vught A.J. van, prof. dr.Rademaker C.M.A., dr.Bollen C.W., dr.Universiteit Utrecht (UU)2014Children; Paediatrics; Electronic prescribing;
Non-dispensing clinical pharmacists in general practice : training, implementation and clinical effectsHazen A.C.M., PhDBouvy M.L., prof. dr.Wit N.J. de, prof. dr.Bont A.A. de, prof. dr.Zwart D.L.M., dr.Universiteit Utrecht (UU)2018Clinical pharmacist; General practice; Medication reviews; Polypharmacy; Hospitalization; Professional identity;
Integrated assessment of neurocognitive, neurophysiological and pain processing in early clinical drug developmentAmerongen G. van, PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Groeneveld G.J., prof. dr.Universiteit Leiden (UL)2020Clinical pharmacology Pharmacodynamics Pain Human pain models Cannabinoid GABA THC Multiple sclerosis (MS)
Drug-induced psychomimetic symptoms as a model for psychosisKleinloog-Fernández González H.D., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Clinical Pharmacology Psychotic Disorders Clinical Trial Drug evaluation Biological Models
Making things easier: how to improve antiviral drug treatment for childrenBastiaans D.E.T., dr.Burger D.M., prof. dr.Radboud Universiteit (RU)2016Clinical pharmacology; Antiviral drug treatment;
Clinical pharmacology of novel anticancer drug formulationsStuurman F.E, PhDSchellens J.H.M., prof. dr.Beijnen J.H., prof. dr.Universiteit Utrecht (UU)2013Clinical pharmacology; Cancer;
Go to page:
  • of 6